K.J. Harrison & Partners Inc Invitae Corp Transaction History

K.J. Harrison & Partners Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$14.7 - $28.67 $735,000 - $1.43 Million	-50,000 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$24.31 - $33.6 $1.22 Million - $1.68 Million	50,000 New	50,000 $1.43 Million
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $165,300 - $284,650	-5,000 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$28.43 - $44.67 $568,600 - $893,400	-20,000 Reduced 80.0%	5,000 $217,000
Q2 2020 Aug 03, 2020	BUY	$11.71 - $30.29 $292,750 - $757,250	25,000 New	25,000 $757,000

Q1 2020 May 05, 2020	SELL	$7.64 - $27.5 $114,600 - $412,500	-15,000 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$15.02 - $20.57 $225,300 - $308,550	15,000 New	15,000 $242,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.